Literature DB >> 25391457

Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women.

Shamima Akter1, Subrina Jesmin1, Yoshio Iwashima2, Sakuramoto Hideaki3, Md Arifur Rahman4, Md Majedul Islam5, Masao Moroi6, Nobutake Shimojo3, Naoto Yamaguchi7, Takashi Miyauchi3, Satoru Kawano3, Taro Mizutani3, Yuhei Kawano2.   

Abstract

Endothelin-1 (ET-1) is a potential marker of the endothelial dysfunction, which has been shown to be elevated in hypertensive subjects. No previous study has investigated the circulatory level of ET-1 and hypertension in a South Asian country. The present study assessed the circulating levels of ET-1 in subjects with or without hypertension and further examined the association of ET-1 with clinical and metabolic parameters. A total of 2543 rural Bangladeshi women with a mean age of 44.5 years were studied using a cross-sectional survey. Multiple regressions were used to examine the association between the circulatory ET-1 levels and hypertension. The prevalence of hypertension was 29.3%. The ET-1 levels were significantly higher in the hypertensive (mean 3.08 pg ml(-1), s.e. (0.19)) than in the non-hypertensive subjects (mean 2.01 pg ml(-1), s.e. (0.03)) (P = 0.001). After adjusting for age, the ET-1 level had significant positive associations with the diastolic blood pressure (P = 0.002), systolic blood pressure (P = 0.001), mean arterial pressure (P = 0.002) and fasting blood glucose (P = 0.002). In a tertile analysis, we found that hypertension in the subjects was significantly increased as the levels of ET-1 increased (P for the trend = 0.001). In a stepwise multiple regression analysis, after adjusting for age and all other potential variables, we found that the mean arterial pressure and the fasting plasma levels have significant associations with the ET-1 level. The present study demonstrates that there is a higher concentration of ET-1 among the hypertensive subjects in an apparently healthy population of Bangladeshi rural women. The relationship between ET-1 and hypertension requires further investigation to define the clinical utility and predictive value of serum ET-1 levels for hypertension for a South Asian population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25391457     DOI: 10.1038/hr.2014.160

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  31 in total

1.  Integrated cardiac, renal, and endocrine actions of endothelin.

Authors:  W L Miller; M M Redfield; J C Burnett
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells.

Authors:  I Komuro; H Kurihara; T Sugiyama; M Yoshizumi; F Takaku; Y Yazaki
Journal:  FEBS Lett       Date:  1988-10-10       Impact factor: 4.124

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

5.  Plasma immunoreactive endothelin in essential hypertension.

Authors:  M Kohno; K Yasunari; K Murakawa; K Yokokawa; T Horio; T Fukui; T Takeda
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

6.  Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy.

Authors:  Ralph V Shohet; Yaz Y Kisanuki; Xiao-Song Zhao; Zakir Siddiquee; Fatima Franco; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

7.  Elevated endothelin-1 plasma concentration in patients with essential hypertension.

Authors:  A Januszewicz; M Lapiński; B Symonides; E Dabrowska; A Kuch-Wocial; E Trzepla; H Ignatowska-Switalska; B Wocial; J Chodakowska; W Januszewicz
Journal:  J Cardiovasc Risk       Date:  1994-06

8.  Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study.

Authors:  Yuji Hirai; Hisashi Adachi; Yoshihisa Fujiura; Akiko Hiratsuka; Mika Enomoto; Tsutomu Imaizumi
Journal:  J Hypertens       Date:  2004-04       Impact factor: 4.844

Review 9.  Epidemiology of hypertension.

Authors:  P K Whelton
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

10.  Contribution of endogenous generation of endothelin-1 to basal vascular tone.

Authors:  W G Haynes; D J Webb
Journal:  Lancet       Date:  1994-09-24       Impact factor: 79.321

View more
  8 in total

1.  Dual NEP/ECE inhibition improves endothelial function in mesenteric resistance arteries of 32-week-old SHR.

Authors:  Pieter Lemkens; Leon Ja Spijkers; Merlijn J Meens; Jelly Nelissen; Ben Janssen; Stephan Lm Peters; Paul Mh Schiffers; Jo Gr De Mey
Journal:  Hypertens Res       Date:  2017-03-16       Impact factor: 3.872

2.  Abnormal correlation of circulating endothelial progenitor cells and endothelin-1 concentration may contribute to the development of arterial hypertension in childhood acute lymphoblastic leukemia survivors.

Authors:  Tomasz Ociepa; Magdalena Bartnik; Karolina Zielezinska; Mai Prokowska; Elzbieta Urasinska; Tomasz Urasinski
Journal:  Hypertens Res       Date:  2016-03-03       Impact factor: 3.872

3.  The association of endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the SABPA study.

Authors:  Christine Susara du Plooy; Catharina Martha Cornelia Mels; Hugo Willem Huisman; Ruan Kruger
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872

Review 4.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Authors:  Amy R Nelson; Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 5.  Emerging concepts for patients with treatment-resistant hypertension.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Trends Cardiovasc Med       Date:  2016-05-17       Impact factor: 6.677

Review 6.  Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders.

Authors:  Manuel Gómez-Guzmán; Alba Rodríguez-Nogales; Francesca Algieri; Julio Gálvez
Journal:  Mar Drugs       Date:  2018-07-28       Impact factor: 5.118

Review 7.  Shared Molecular Mechanisms among Alzheimer's Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review.

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Vincenzo Zaccone; Emanuele Guerrieri; Gianluca Moroncini; Simona Luzzi; Mauro Silvestrini
Journal:  Biomedicines       Date:  2022-02-14

8.  Inverse Correlation Between Plasma Adropin and ET-1 Levels in Essential Hypertension: A Cross-Sectional Study.

Authors:  Xiaosong Gu; Hui Li; Xinyi Zhu; Haibo Gu; Jianchang Chen; Luchen Wang; Pamela Harding; Weiting Xu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.